The U.S. Food and Drug Administration said on Friday it had approved Daiichi San...
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid
AstraZeneca in March signed a licensing and collaboration deal that committed the British drugmaker to pay up to $6.9 billion to its Japanese partner Daiichi. The agency said further clinical trials may be required to verify and describe the benefits of Enhertu, which is still under development.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA grants accelerated approval for Astellas, Seattle Genetics' bladder cancer drugU.S. Food and Drug Administration said on Wednesday it approved Astellas Pharma ...
Consulte Mais informação »
Merck receives FDA approval for Ebola vaccineThe U.S. Food and Drug Administration said on Thursday it granted approval to dr...
Consulte Mais informação »
Novartis wins Medicaid approval for new sickle cell drug in key U.S. statesNovartis AG has secured Medicaid coverage for a pricey new sickle cell disease t...
Consulte Mais informação »
Gabapentin, Opioids a Deadly Duo: FDAThe decision to order the new warnings is based on a review of data from numerous sources, including case reports, observational studies, human trials and animal studies.
Consulte Mais informação »
Brazil poll shows rising rejection of BolsonaroThe approval rating of Brazilian President Jair Bolsonaro's government is d...
Consulte Mais informação »